MoU Or Statutory Fix? FDA/CMS “Harmonization” Strategies Are Under Review
This article was originally published in The Gray Sheet
Executive Summary
FDA and CMS will likely produce a memorandum of understanding soon after the HHS Secretary's Advisory Panel on Regulatory Reform holds its final meeting Oct. 1-2 in Washington, D.C